Biodexa appoints ann merchant to the board of directors

Biodexa pharmaceuticals plc (“biodexa” or the “company”) biodexa appoints ann merchant to the board of directors cardiff, united kingdom, dec. 29, 2023 (globe newswire) – biodexa pharmaceuticals plc (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs including type 1 diabetes and rare / orphan brain cancers, is pleased to announce the appointment of ann merchant to the board of directors of the company as non-executive director with effect from 31 december 2023. since 2018, ann merchant has served as vice president for morphosys, and currently as head of global supply chain and external operations.
BDRX Ratings Summary
BDRX Quant Ranking